TickerFactsScreenerDevelopers

Atara Biotherapeutics, Inc. (ATRA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$3.73M2013: -$11.02M2014: $103.18M2015: $315.10M2016: $253.74M2017: $177.86M2018: $339.22M2019: $290.78M2020: $462.34M2021: $279.61M2022: $126.64M2023: $99.23M2024: -$97.28M2025: -$38.50M-$38.50M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$38.50M+60.4%
2024-$97.28M-198.0%
2023$99.23M-21.6%
2022$126.64M-54.7%
2021$279.61M-39.5%
2020$462.34M+59.0%
2019$290.78M-14.3%
2018$339.22M+90.7%
2017$177.86M-29.9%
2016$253.74M-19.5%
2015$315.10M+205.4%
2014$103.18M+1036.6%
2013-$11.02M-195.6%
2012-$3.73M—